Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players芒鈧劉 financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Request Free Sample
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.
Speak to Analyst

ADME Toxicology Testing Market Research Report, by Method (Cellular Assay, Ex-vivo), Technology (Cell Culture, Biochemical Assay, Molecular Imaging), Application (Systemic, Renal), End-User (Hospital & Clinic, Diagnostic Centre)- Forecast Till 2032.


ID: MRFR/LS/5480-HCR | 90 Pages | Author: Rahul Gotadki| April 2024

ADME Toxicology Testing Market Overview


The ADME Toxicology Testing Market is projected to reach USD 3.02 Billion by 2032 at 12.1% CAGR during the forecast period 2023-2032. The ADME Toxicology Screening System is an integrated workstation that describes the properties of pharmacological molecules in terms of absorption, distribution, metabolism, and excretion. The system is equipped with sample testing software that is highly integrated. It also performs precise toxicity tests for drug research and biopharmaceutical manufacturing. The expanding use of ADME toxicology testing by pharmaceutical and biotechnology companies, as well as growing concerns over the use of animals in clinical trials, have aided the expansion of the toxicology testing industry. The region of Asia-Pacific was predicted to be the fastest-growing region for ADME toxicity testing globally. Increased efforts for the development of new diagnostic equipment and the adoption of modern technologies to improve the standard of diagnostic tests. The market is primarily driven by increased medication research and development and rising demand for various disease treatments. Pharmaceutical businesses have benefited from increasing technology breakthroughs and early identification of toxicology in R&D by reducing drug discovery time, expense, and test complications. Furthermore, rising healthcare awareness and increased government and private sector investments in the healthcare sector are expected to drive market expansion. However, high test prices and strict government norms and regulations related to ADME toxicity testing are key roadblocks to industry expansion. During the forecast period, ongoing R&D in the field of ADME toxicity testing is expected to open up new opportunities.

ADME Toxicology Testing Market Segment Insights:


The ADME Toxicology Testing Market is segmented on the basis of method, technology, application, and end-user. The Market, by method is categorised into cellular assay, biochemical assay, in silica, and ex-vivo. The technology segment is categorised into cell culture, high throughput, molecular imaging, and OMICS technology. On the basis of application, the ADME Toxicology Testing Market is segmented into systemic toxicity, renal toxicity, hepatotoxicity, neurotoxicity, and others. On the basis of end-user, the market is segmented into hospitals and clinics, diagnostic centres, pathological labs, and others.


On the basis of region, the global ADME Toxicology Testing Market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas is sub-segmented into North America and South America. The North American region is further segmented into the US and Canada. The European region is divided into two, namely, Western Europe and Eastern Europe. Western Europe is further classified into Germany, Italy, France, the UK, Spain, and the rest of Western Europe. The Asia-Pacific region is sub-segmented into Japan, China, India, Australia, the Republic of Korea, and the rest of Asia-Pacific. The Middle Eastern and African region is sub-segmented into the United Arab Emirates, Saudi Arabia, Oman, Kuwait, Qatar, and the rest of the Middle East and Africa.


Regional Market Summary


It is projected that the Americas dominated the global ADME toxicology testing market owing to the growth in the North America region which is largely attributed to the factors such as increase in research funding, growing awareness on the benefits of ADME toxicology testing for commercial industries, and high adoption of toxicology testing in research. These factors have cumulatively influenced the growth of the market in this regionEurope stood second largest in the ADME toxicology testing market owing to high acceptance of toxicology testing in research. Additionally, development in research expenditure was also responsible for the development of market. Moreover, in January 2014, Cyprotex PLC, a UK based company signed an acquisition agreement with CeeTox, Inc. for its business. The company intended to expand its portfolio for in-vitro toxicity assays and screening services to the Cosmetics and Personal Care Industry.


Asia-Pacific was projected to be the fastest growing region for the global ADME toxicology testing market in 2017. The factors attributed to the due to increased efforts for development of new diagnostic devices and adoption of newer technologies to improve the standard of diagnostics assays being supplied. China and Japan are key countries contributing to market growth.The Middle East and Africa holds the least share in the global ADME toxicology testing market due to the presence of poor health expenditure and economically diverse countries. However, the market is expected to witness growth due to increasing toxicology care programs in the Middle East.


ADME Toxicology Testing Market Segmentation


ADME toxicology testing Method Outlook



  • 聽 聽 聽 聽Cellular Assay

  • 聽 聽 聽 聽Biochemical Assay

  • 聽 聽 聽 聽In Silica

  • 聽 聽 聽 聽Ex-vivo


ADME Toxicology Testing Technology Outlook



  • 聽 聽 聽 聽Cell Culture

  • 聽 聽 聽 聽High Throughput

  • 聽 聽 聽 聽Molecular Imaging

  • 聽 聽 聽 聽OMICS Technology


ADME toxicology Testing Application Outlook



  • 聽 聽 聽 聽Systemic Toxicity

  • 聽 聽 聽 聽Renal Toxicity

  • 聽 聽 聽 聽Hepatotoxicity

  • 聽 聽 聽 聽Neurotoxicity

  • 聽 聽 聽 聽Others


ADME Toxicology Testing End-Users Outlook



  • 聽 聽 聽 Hospitals and clinics

  • 聽 聽 聽 Diagnostic centers

  • 聽 聽 聽 Pathological Labs

  • 聽 聽 聽 Others


ADME Toxicology Testing Region Outlook



  • 聽 聽 聽 聽Americas

  • 聽 聽 聽 聽Europe

  • 聽 聽 聽 聽Asia-Pacific

  • 聽 聽 聽 Middle East & Africa


Global ADME toxicology testing Global聽Market, by Key Players:



  • 聽 聽 聽 聽Promega Corporation

  • 聽 聽 聽 聽Agilent Technologies, Inc.

  • 聽 聽 聽 聽Thermo Fisher Scientific, Inc.

  • 聽 聽 聽 聽Bio-Rad Laboratories, Inc.

  • 聽 聽 聽 聽Beckman Coulter, Inc.

  • 聽 聽 聽 聽Cellartis AB

  • 聽 聽 聽 聽Cyprotex PLC.

  • 聽 聽 聽 聽Life Technologies Corporation

  • 聽 聽 聽 聽Optivia Biotechnology, Inc.

  • 聽 聽 聽 聽Accelrys, Inc.

  • 聽 聽 聽 聽Molecular Discovery Ltd.

  • 聽 聽 聽 聽Cyprotex PLC

  • 聽 聽 聽 聽MultiCASE, Inc.


Recent Development


Machine learning operations platform Chief will be launched in July 2021. The first no-code, pay-as-you-go artificial intelligence (AI) platform for drug development has been established by AI in collaboration with the Medicines Discovery Catapult increasing the stake of the ADME Toxicology Testing Market.聽Mydecine Innovations Group, an emerging biopharma and life sciences company dedicated to the research, development, and acceptance of alternative nature-sourced medicine for mainstream use, announced the launch of its in-silico drug discovery program in collaboration with University of Alberta researchers in June 2021.

Intended Audience:



  • Pharmaceutical companies

  • Biotechnological institutes

  • Diagnostics Laboratories

  • Pathological Institutes

  • Government and private laboratories

  • Research and Development (R&D) companies

  • Medical research laboratories

  • Market research and consulting service providers

Report Attribute/Metric Details
聽聽Market Size 聽聽USD聽3.02 Billion
聽聽CAGR 聽聽12.1%
聽聽Base Year 聽聽2021
聽聽Forecast Period 聽聽2023-2032
聽聽Historical Data 聽聽2020
聽聽Forecast Units 聽聽Value (USD Million)
聽聽Report Coverage 聽聽Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
聽聽Segments Covered 聽聽Method, Technology, Application, and End-user
聽聽Geographies Covered 聽聽North America, Europe, Asia-Pacific, and Rest of the World (RoW)
聽聽Key Vendors 聽聽Promega Corporation, Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Beckman Coulter, Inc., Cellartis AB, Cyprotex PLC., Life Technologies Corporation, Optivia Biotechnology, Inc., Accelrys, Inc., Molecular Discovery Ltd., Cyprotex PLC, MultiCASE, Inc., Caliper Life Sciences, Inc., Xceleron, Inc., ACEA Biosciences, Inc., Albany Molecular Research, Inc., CeeTox, Inc., and others.
聽聽Key Market Opportunities 路聽 Increase in research funding 路聽 Growing awareness on the benefits of ADME toxicology testing for commercial industries 路聽 High adoption of toxicology testing in research
聽聽Key Market Drivers 路聽 Rising application of ADME toxicology testing by pharmaceuticals and biotechnology companies 路聽 Growing concerns over application of animals in clinical trials


Frequently Asked Questions (FAQ) :

The ADME Toxicology Testing Market is expected to register a CAGR of 12.1% during forecast period upto 2032.

The Growing concerns over application of animals in clinical trials is the major driving factor of ADME Toxicology Testing Market.

Promega Corporation, Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Beckman Coulter, Inc., Cellartis AB, Cyprotex PLC., Life Technologies Corporation, Optivia Biotechnology, Inc., Accelrys, Inc., Molecular Discovery Ltd., Cyprotex PLC, MultiCASE, Inc., Caliper Life Sciences, Inc., Xceleron, Inc., ACEA Biosciences, Inc., Albany Molecular Research, Inc., CeeTox, Inc., and others.

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Request Free Sample
Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.
Ask for Customization